Loading...

Shanghai Pharma teams up with JD.com to sell drugs online

Image

18-May-15 State-backed pharmaceutical group Shanghai Pharmaceutical Holding has teamed up with e-commerce company JD.com to further tap China's booming online drug sales market. Shanghai Pharma will operate JD's online prescription drug sales platform under an exclusive agreement, and share drug-sales related data and resources. [image: Reuters]

Read More

Thailand will curb medicine prices to rein in healthcare costs

Image

16-May-15 The Thai government is looking at reining in skyrocketing healthcare costs at private hospitals by controlling the price of medicines and hospital services. Private hospitals will also be required to post the price of drugs and services on their websites and other channels so patients are informed in advance before commencing treatment. [image: The Nation]

Read More

Australia to boost its engagement in China's health sector

Image

15-May-15 Australia is seeking closer business ties with China in areas such as medical devices, aged care, health information technology, clinical trials, hospital management, pharmaceuticals and health foods. But Australian companies will need to prepare themselves for strong competition as the Chinese government pushes hospitals to use more domestically made medical devices. [image: The Conversation_Lukas Coch / AAP]

Read More

Plan to scrap drug mark-up in China's county hospitals may impact quality

Image

13-May-15 China's State Council has published a plan to overhaul thousands of public county hospitals nationwide. A key reform is barring a 15% drug mark-up, which some say causes over-prescription of expensive imported drugs. An economist at the University of International Business & Economics in Beijing said hospitals will now have to raise prices on other services or lower quality levels. [image: Caixin Online]

Read More

Pfizer's foray into Laos healthcare market

Image

13-May-15 In a bid to expand further into Southeast Asia, Pfizer has struck an agreement on the Laos market with distributor DKSH. Under the deal, DKSH will be the sole market expansion services provider for Pfizer's entire range of pharmaceutical products in Laos. The agreement is an extension of a successful collaboration that also includes Cambodia and Thailand. [image: Bio Spectrum]

Read More
Share